Current BTA guidelines and statements

 

The following are in chronological order with the most recent first: 

 

July 2023 

 

Use of liothyronine (T3) in hypothyroidism

 

 

March 2020

 

The COVID-19 pandemic presents significant challenges to us all. The following statements regarding the management of thyroid disease have been formulated to provide clinical advice to medical colleagues during this time 

 

 

 

 

 

1st December 2019

Radioiodine has been used very effectively to treat thyroid overactivity since the 1940’s, but a recent study has cast doubt on its safety, causing considerable concern. A joint position statement from the British Thyroid Association and Society for Endocrinology highlights important limitations of this study which may confound its conclusions and calls for caution in interpretation of its results

 

October 2017 

The BTA has responded to the ongoing consultation process by NHS England on prescription of Liothyronine (T3) in primary care. The full response can be found here 

 

2016

Switching from Liothyronine (LT-3) to Levothyroxine (LT-4)? 

 

2015

Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee 

Click here

 

2014

The British Thyroid Association Guidelines for the Management of Thyroid Cancer 

Click here 

 

2007

Armour Thyroid (USP) and combined thyroxine/tri-iodothyronine as Thyroid Hormone Replacement 

Click here

 

2006

The UK Guidelines for the use of Thyroid Function Tests 

Click here 

 

 

 
 

Guidelines from other bodies

We are responsible for the development and production of guidelines in various thyroidology subject areas but in principle will endorse guidelines prepared by other societies.

Please click here to download our Guidelines Endorsement Statement 

 

 

Other useful guidelines

 

2020

 

2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction

Subject: Pregnancy/reproduction

Click here

 

Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome

Subject: Thyroid tumours

Click here

 

2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules

Subject: Thyroid tumours

Click here

 

2019

2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer

Subject: Thyroid tumours

Click here 

 

2019 European Thyroid Association Guidelines on the Management of Thyroid Dysfunction following Immune Reconstitution Therapy

Subject: Hyperthyroidism

Click here

 

2018

 

European Thyroid Association (ETA) and Thyroid Federation International (TFI) Joint Position Statement on the Interchangeability of Levothyroxine Products in EU Countries

Subject: Hypothyroidism

Click here 

 

2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism

Subject: Hypothyroidism

Click here 

 

2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism

Subject: Hyperthyroidism

Click here

 

The Krakow Declaration on Iodine: Tasks and Responsibilities for Prevention Programs Targeting Iodine Deficiency Disorders

Subject: Iodine

Click here 

 

2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction

Hyperthyroidism

Click here

 

2017

2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum

Subject: Pregnancy/reproduction

Click here 

 

European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS

Subject: Thyroid Tumours

Click here 

 

European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics

Subject: Thyroid tumours

Click here

 

2016

The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

Subject: Thyroid eye disease

Click here 

 

2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

Subject: Hyperthyroidism

Click here

 

2015

The Management of Patients with Graves' Orbitopathy - Clinical Medicine 2015

Subject: Thyroid eye disease

Click here

 

2011

The diagnosis and management of primary hypothyroidism - Royal College of Physicians - Revised 2011

Subject: Hypothyroidism

Click here

 

Guidelines from the American Thyroid Association

Click here

 

To download the clinical practice guidelines from the Endocrine Society

Click here

 

To download the clinical practice guidelines from the American Association of Clinical Endocrinologists

Click here

 

To download the British Fluoridation Statement on Thyroid Disorders and Fluoride (2006)

Click here